Realcan Pharmaceutical Group Co., Ltd. at its Annual General Meeting of 2022 held on 19 May 2023, approved the appointment of Zhang Shoukai, Li Zhe and Wu Liyan as Non-Independent Director, Liu Xijun, Wang Jifa and Sun Kaoxiang as Independent Director and Zhang Yan as Non-Employee Supervisor.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.29 CNY | +0.44% |
|
+6.02% | -29.97% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-29.97% | 469M | |
+26.00% | 75.86B | |
-5.06% | 23.51B | |
+13.09% | 8.76B | |
+1.47% | 8.31B | |
-33.89% | 6.66B | |
+19.11% | 5.45B | |
+1.79% | 4.05B | |
-10.28% | 3.8B | |
-10.01% | 3.33B |
- Stock Market
- Equities
- 002589 Stock
- News Realcan Pharmaceutical Group Co., Ltd.
- Realcan Pharmaceutical Group Co., Ltd. Approves the Executive Appointments